Your session is about to expire
← Back to Search
Patient Empowerment Interventions for Lung Cancer Screening (Empower-LCS Trial)
N/A
Waitlist Available
Led By Gelareh Sadigh, MD
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 6 months after enrollment
Awards & highlights
No Placebo-Only Group
Summary
This trial will test if a multi-level intervention can increase the rate of LDCT ordering to detect lung cancer early & reduce mortality rate.
Who is the study for?
This trial is for English, Spanish, or Vietnamese speakers aged 50-80 who are current smokers or quit within the last 15 years. They must have a history of heavy smoking (20 pack-years), an upcoming primary care appointment at UCI Health in Orange County, and no prior lung cancer or recent chest CT scans.
What is being tested?
The study tests if reminders to doctors and patients about lung cancer screening eligibility, patient education on lung cancer screening, financial navigation help, and reminders to discuss screening can increase low dose CT scan orders within six months after enrolling.
What are the potential side effects?
Since this trial involves educational materials and reminders rather than medical treatments or drugs, there are no direct side effects associated with these interventions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 6 months of enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 6 months of enrollment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Order of LDCT
Secondary study objectives
Knowledge about lung cancer and screening
LCS discussion
Perceived Benefit of lung cancer screening
+6 moreOther study objectives
Patient and provider experience with intervention
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Empower LCSExperimental Treatment4 Interventions
Patient will be given education material(addressing knowledge barriers); patients' referral to financial navigation resources (addressing health-related social risks); and patients' reminder to discuss LCS during PCP visit. Providers will also be notified of eligibility of their patients to receive LCS.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient education
2011
Completed Phase 2
~9240
Find a Location
Who is running the clinical trial?
University of California, IrvineLead Sponsor
566 Previous Clinical Trials
1,932,978 Total Patients Enrolled
Gelareh Sadigh, MDPrincipal InvestigatorUniversity of California, Irvine
2 Previous Clinical Trials
121 Total Patients Enrolled